{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T21:09:20Z","timestamp":1788728960651,"version":"build-2803163510"},"reference-count":202,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004773","name":"Henan University","doi-asserted-by":"publisher","award":["KFZD25002"],"award-info":[{"award-number":["KFZD25002"]}],"id":[{"id":"10.13039\/501100004773","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82401723"],"award-info":[{"award-number":["82401723"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013142","name":"Key Research and Development Project of Hainan Province","doi-asserted-by":"publisher","award":["242102310190"],"award-info":[{"award-number":["242102310190"]}],"id":[{"id":"10.13039\/501100013142","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["262300421549"],"award-info":[{"award-number":["262300421549"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.pharmthera.2026.109107","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T23:10:58Z","timestamp":1788045058000},"page":"109107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The brain angiotensin converting enzyme 2 and angiotensin-(1\u20137) as potential therapeutic targets for the central nervous system diseases"],"prefix":"10.1016","volume":"287","author":[{"given":"Xiaowen","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaofeng","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahua","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Cen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2026.109107_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117388","article-title":"Telmisartan\/17\u03b2-estradiol mitigated cognitive deficit in an ovariectomized rat model of Alzheimer\u2019s disease: Modulation of ACE1\/ACE2 and AT1\/AT2 ratio","volume":"245","author":"Abdelkader","year":"2020","journal-title":"Life Sciences"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109107_bb0010","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.sjbs.2020.01.026","article-title":"Role of brain renin angiotensin system in neurodegeneration: An update","volume":"27","author":"Abiodun","year":"2020","journal-title":"Saudi Journal of Biological Sciences"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0015","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.semcancer.2020.01.010","article-title":"Structure-based drug repositioning: Potential and limits","volume":"68","author":"Adasme","year":"2021","journal-title":"Seminars in Cancer Biology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109107_bb0020","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1515\/HMBCI.2011.123","article-title":"Regulation of the hypothalamic-pituitary-adrenal axis by neuropeptides","volume":"7","author":"Aguilera","year":"2011","journal-title":"Hormone Molecular Biology and Clinical Investigation"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109107_bb0025","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18495","article-title":"The potential role of brain renin-angiotensin system in the neuropathology of Parkinson disease: Friend, foe or turncoat?","volume":"28","author":"Al-Qahtani","year":"2024","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109107_bb0030","doi-asserted-by":"crossref","first-page":"R1187","DOI":"10.1152\/ajpregu.00580.2001","article-title":"Hypotensive effect of ANG II and ANG-(1-7) at the caudal ventrolateral medulla involves different mechanisms","volume":"283","author":"Alzamora","year":"2002","journal-title":"American Journal of Physiology. Regulatory, Integrative and Comparative Physiology"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2020.170369","article-title":"Glycopeptide drugs: A pharmacological dimension between \u201csmall molecules\u201d and \u201cbiologics\u201d","volume":"131","author":"Apostol","year":"2020","journal-title":"Peptides"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109107_bb0040","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1124\/pr.118.017129","article-title":"Novel therapeutic approaches targeting the renin-angiotensin system and associated peptides in hypertension and heart failure","volume":"71","author":"Arendse","year":"2019","journal-title":"Pharmacological Reviews"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109107_bb0045","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1021\/acschemneuro.0c00076","article-title":"GLUT-1: An effective target to deliver brain-derived neurotrophic factor gene across the blood brain barrier","volume":"11","author":"Arora","year":"2020","journal-title":"ACS Chemical Neuroscience"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109107_bb0050","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1212\/01.wnl.0000344171.22760.24","article-title":"Use of antihypertensives and the risk of Parkinson disease","volume":"72","author":"Ascherio","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2023.173706","article-title":"Signaling pathways and genetics of brain renin angiotensin system in psychiatric disorders: State of the art","volume":"236","author":"Barak","year":"2024","journal-title":"Pharmacology Biochemistry and Behavior"},{"issue":"16","key":"10.1016\/j.pharmthera.2026.109107_bb0060","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1212\/01.wnl.0000303818.38960.44","article-title":"Use of antihypertensives and the risk of Parkinson disease","volume":"70","author":"Becker","year":"2008","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109107_bb0065","doi-asserted-by":"crossref","first-page":"H1416","DOI":"10.1152\/ajpheart.00141.2007","article-title":"Immunofluorescence localization of the receptor Mas in cardiovascular-related areas of the rat brain","volume":"293","author":"Becker","year":"2007","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109107_bb0070","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1113\/EP086957","article-title":"Neuroprotection by post-stroke administration of an oral formulation of angiotensin-(1-7) in ischaemic stroke","volume":"103","author":"Bennion","year":"2018","journal-title":"Experimental Physiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109107_bb0075","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000108758","article-title":"Angiotensin-(1-7) prevents activation of NADPH oxidase and renal vascular dysfunction in diabetic hypertensive rats","volume":"28","author":"Benter","year":"2008","journal-title":"American Journal of Nephrology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109107_bb0080","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jad.2012.07.024","article-title":"Angiotensin-(1-7) central administration induces anxiolytic-like effects in elevated plus maze and decreased oxidative stress in the amygdala","volume":"145","author":"Bild","year":"2013","journal-title":"Journal of Affective Disorders"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109107_bb0085","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1161\/HYPERTENSIONAHA.116.08188","article-title":"Monotherapy with major antihypertensive drug classes and risk of hospital admissions for mood disorders","volume":"68","author":"Boal","year":"2016","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109107_bb0090","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00441-006-0190-8","article-title":"The CNS renin-angiotensin system","volume":"326","author":"von Bohlen und Halbach","year":"2006","journal-title":"Cell and Tissue Research"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0095","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejim.2023.01.005","article-title":"Pathophysiology of cough with angiotensin-converting enzyme inhibitors: How to explain within-class differences?","volume":"110","author":"Borghi","year":"2023","journal-title":"European Journal of Internal Medicine"},{"issue":"7339","key":"10.1016\/j.pharmthera.2026.109107_bb0100","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/bmj.324.7339.699","article-title":"Use of ramipril in preventing stroke: Double blind randomised trial","volume":"324","author":"Bosch","year":"2002","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109107_bb0105","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1515\/JBCPP.2003.14.4.323","article-title":"Captopril and enalapril improve cognition and depressed mood in hypertensive patients","volume":"14","author":"Braszko","year":"2003","journal-title":"Journal of Basic and Clinical Physiology and Pharmacology"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109107_bb0110","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1007\/s11357-020-00196-y","article-title":"Angiotensin (1-7) delivered orally via probiotic, but not subcutaneously, benefits the gut-brain axis in older rats","volume":"42","author":"Buford","year":"2020","journal-title":"Geroscience"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109107_bb0115","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.tem.2004.03.001","article-title":"ACE2, a new regulator of the renin-angiotensin system","volume":"15","author":"Burrell","year":"2004","journal-title":"Trends in Endocrinology and Metabolism"},{"issue":"8010","key":"10.1016\/j.pharmthera.2026.109107_bb0120","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41586-024-07311-5","article-title":"Network-level encoding of local neurotransmitters in cortical astrocytes","volume":"629","author":"Cahill","year":"2024","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109107_bb0125","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.toxicon.2011.07.013","article-title":"Bradykinin-potentiating peptides: Beyond captopril","volume":"59","author":"Camargo","year":"2012","journal-title":"Toxicon"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2025.149739","article-title":"ACE2\/Angiotensin-(1-7)\/Mas and the brain","volume":"1863","author":"Campagnole-Santos","year":"2025","journal-title":"Brain Research"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109107_bb0135","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.peptides.2009.06.028","article-title":"Angiotensin-(1-7) antagonist, A-779, microinjection into the caudal ventrolateral medulla of renovascular hypertensive rats restores baroreflex bradycardia","volume":"30","author":"Cangussu","year":"2009","journal-title":"Peptides"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109107_bb0140","first-page":"1299","article-title":"Therapeutic delivery of Ang(1-7) via genetically modified probiotic: A dosing study","volume":"75","author":"Carter","year":"2020","journal-title":"The Journals of Gerontology: Series A, Biological Sciences and Medical Sciences"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109107_bb0145","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/jphp.12033","article-title":"Alteration in P-glycoprotein at the bloodbrain barrier in the early period of MCAO in rats","volume":"65","author":"Cen","year":"2013","journal-title":"Journal of Pharmacy and Pharmacology"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109107_bb0150","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/HYPERTENSIONAHA.116.07874","article-title":"Heteromerization between the bradykinin B2 receptor and the angiotensin-(1-7) Mas receptor: Functional consequences","volume":"68","author":"Cerrato","year":"2016","journal-title":"Hypertension"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109107_bb0155","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2251","article-title":"Brain-derived neurotrophic factor attenuates cognitive impairment and motor deficits in a mouse model of Parkinson\u2019s disease","volume":"11","author":"Chang","year":"2021","journal-title":"Brain and Behavior"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109107_bb0160","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1097\/00004872-200018120-00019","article-title":"Modulation of the baroreflex control of heart rate by angiotensin-(1-7) at the nucleus tractus solitarii of normotensive and spontaneously hypertensive rats","volume":"18","author":"Chaves","year":"2000","journal-title":"Journal of Hypertension"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109107_bb0165","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1161\/HYPERTENSIONAHA.111.00202","article-title":"Angiotensin-converting enzyme 2 priming enhances the function of endothelial progenitor cells and their therapeutic efficacy","volume":"61","author":"Chen","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0170","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.neuropharm.2014.01.004","article-title":"Neuronal over-expression of ACE2 protects brain from ischemia-induced damage","volume":"79","author":"Chen","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0175","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.neuroscience.2017.01.027","article-title":"Angiotensin-(1-7) administration attenuates Alzheimer\u2019s disease-like neuropathology in rats with streptozotocin-induced diabetes via Mas receptor activation","volume":"346","author":"Chen","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.573095","article-title":"The spatial and cell-type distribution of SARS-CoV-2 receptor ACE2 in the human and mouse brains","volume":"11","author":"Chen","year":"2021","journal-title":"Frontiers in Neurology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109107_bb0185","article-title":"The ACE2\/Ang-(1-7)\/MasR axis alleviates brain injury after cardiopulmonary resuscitation in rabbits by activating PI3K\/Akt signaling","volume":"15","author":"Cheng","year":"2024","journal-title":"Translational Neuroscience"},{"issue":"7960","key":"10.1016\/j.pharmthera.2026.109107_bb0190","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41586-023-06010-x","article-title":"Inhibitory input directs astrocyte morphogenesis through glial GABABR","volume":"617","author":"Cheng","year":"2023","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109107_bb0195","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-15119-w","article-title":"Microglia clear neuron-released a-synuclein via selective autophagy and prevent neurodegeneration","volume":"11","author":"Choi","year":"2020","journal-title":"Nature Communications"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109107_bb0200","doi-asserted-by":"crossref","first-page":"5847","DOI":"10.1007\/s12035-017-0805-y","article-title":"Paracrine and Intracrine angiotensin 1-7\/Mas receptor Axis in the substantia Nigra of rodents, monkeys, and humans","volume":"55","author":"Costa-Besada","year":"2018","journal-title":"Molecular Neurobiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109107_bb0205","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5853\/jos.2017.02796","article-title":"Treatments to promote neural repair after stroke","volume":"20","author":"Cramer","year":"2018","journal-title":"Journal of Stroke"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.684874","article-title":"The altered anatomical distribution of ACE2 in the brain with Alzheimer\u2019s disease pathology","volume":"9","author":"Cui","year":"2021","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109107_bb0215","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13480","article-title":"Activation of angiotensin-converting enzyme 2\/angiotensin (1-7)\/mas receptor axis triggers autophagy and suppresses microglia proinflammatory polarization via forkhead box class O1 signaling","volume":"20","author":"Dang","year":"2021","journal-title":"Aging Cell"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109107_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17010012","article-title":"Evaluation of biologics ACE2\/Ang(1-7) encapsulated in plant cells for FDA approval: Safety and toxicology studies","volume":"17","author":"Daniell","year":"2025","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109107_bb0225","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.apsb.2024.10.004","article-title":"Oxidative stress and inflammation in the pathogenesis of neurological disorders: Mechanisms and implications","volume":"15","author":"Dash","year":"2025","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0230","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2147\/JIR.S392599","article-title":"AVE 0991 suppresses astrocyte-mediated neuroinflammation of Alzheimer\u2019s disease by enhancing autophagy","volume":"16","author":"Deng","year":"2023","journal-title":"Journal of Inflammation Research"},{"issue":"8092","key":"10.1016\/j.pharmthera.2026.109107_bb0235","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41586-025-09619-2","article-title":"The astrocytic ensemble acts as a multiday trace to stabilize memory","volume":"648","author":"Dewa","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0240","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.nbd.2015.08.014","article-title":"Vascular dysfunction in the pathogenesis of Alzheimer\u2019s disease - A review of endothelium-mediated mechanisms and ensuing vicious circles","volume":"82","author":"Di Marco","year":"2015","journal-title":"Neurobiology of Disease"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109107_bb0245","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41582-025-01159-7","article-title":"Huntington disease: Somatic expansion, pathobiology and therapeutics","volume":"22","author":"Donaldson","year":"2026","journal-title":"Nature Reviews Neurology"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109107_bb0250","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0255","doi-asserted-by":"crossref","first-page":"7007","DOI":"10.2147\/JIR.S343575","article-title":"Angiotensin-(1-7) analogue AVE0991 modulates astrocyte-mediated Neuroinflammation via lncRNA SNHG14\/miR-223-3p\/NLRP3 pathway and offers neuroprotection in a transgenic mouse model of Alzheimer\u2019s disease","volume":"14","author":"Duan","year":"2021","journal-title":"Journal of Inflammation Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109107_bb0260","doi-asserted-by":"crossref","first-page":"E794","DOI":"10.1152\/ajpendo.00791.2007","article-title":"Transforming growth factor-\u03b2 prevents osteoblast apoptosis induced by skeletal unloading via PI3K\/Akt, Bcl-2, and phospho-bad signaling","volume":"294","author":"Dufour","year":"2008","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109107_bb0265","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/med.2610120203","article-title":"The discovery of DuP 753, a potent, orally active nonpeptide angiotensin II receptor antagonist","volume":"12","author":"Duncia","year":"1992","journal-title":"Medicinal Research Reviews"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109107_bb0270","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1113\/expphysiol.2007.040311","article-title":"Brain angiotensin-converting enzymes: Role of angiotensin-converting enzyme 2 in processing angiotensin II in mice","volume":"93","author":"Elased","year":"2008","journal-title":"Experimental Physiology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109107_bb0275","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1124\/jpet.122.001339","article-title":"Is Diminazene an angiotensin-converting enzyme 2 (ACE2) activator? Experimental evidence and implications","volume":"383","author":"Esfahani","year":"2022","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109107_bb0280","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00401-019-02098-6","article-title":"ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer\u2019s disease","volume":"139","author":"Evans","year":"2020","journal-title":"Acta Neuropathologica"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109107_bb0285","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/sj.jcbfm.9600204","article-title":"Cerebral vascular effects of angiotensin II: New insights from genetic models","volume":"26","author":"Faraci","year":"2006","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109107_bb0290","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1161\/CIRCRESAHA.109.208645","article-title":"Brain-selective overexpression of human angiotensin-converting enzyme type 2 attenuates neurogenic hypertension","volume":"106","author":"Feng","year":"2010","journal-title":"Circulation Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109107_bb0295","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00441-012-1354-3","article-title":"Immunohistochemical localization of the angiotensin-(1-7) receptor Mas in the murine forebrain","volume":"348","author":"Freund","year":"2012","journal-title":"Cell and Tissue Research"},{"issue":"21","key":"10.1016\/j.pharmthera.2026.109107_bb0300","first-page":"13304","article-title":"Angiotensin-(1-7) relieves behavioral defects and \u03b1-synuclein expression through NEAT1\/miR-153-3p axis in Parkinson\u2019s disease","volume":"16","author":"Gao","year":"2024","journal-title":"Aging-Us"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109107_bb0305","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1097\/00004872-200309000-00028","article-title":"The study on cognition and prognosis in the elderly (SCOPE): Principal results of a randomized double-blind intervention trial","volume":"21","author":"Gayet","year":"2003","journal-title":"Journal of Hypertension"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2026.109107_bb0310","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11010-008-9884-4","article-title":"Angiotensin metabolites can stimulate receptors of the Mas-related genes family","volume":"319","author":"Gembardt","year":"2008","journal-title":"Molecular and Cellular Biochemistry"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109107_bb0315","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1007\/s00415-018-8827-6","article-title":"Influence of on-going treatment with angiotensin-converting enzyme inhibitor or angiotensin receptor blocker on the outcome of patients treated with intravenous rt-PA for ischemic stroke","volume":"265","author":"Gilliot","year":"2018","journal-title":"Journal of Neurology"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109107_bb0320","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.amjhyper.2005.03.728","article-title":"Antianxiety treatment in patients with excessive hypertension","volume":"18","author":"Grossman","year":"2005","journal-title":"American Journal of Hypertension"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109107_bb0325","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/cvr\/cvq059","article-title":"Astroglia are a possible cellular substrate of angiotensin(1-7) effects in the rostral ventrolateral medulla","volume":"87","author":"Guo","year":"2010","journal-title":"Cardiovascular Research"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109107_bb0330","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1021\/acschemneuro.1c00797","article-title":"Angiotensin-converting enzyme 2 activation mitigates behavioral deficits and neuroinflammatory burden in 6-OHDA induced experimental models of Parkinson\u2019s disease","volume":"13","author":"Gupta","year":"2022","journal-title":"ACS Chemical Neuroscience"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109107_bb0335","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1001\/archneurol.2012.1010","article-title":"Impact of angiotensin receptor blockers on Alzheimer disease neuropathology in a large brain autopsy series","volume":"69","author":"Hajjar","year":"2012","journal-title":"Archives of Neurology"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109107_bb0340","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/archinternmed.2011.1391","article-title":"Effect of antihypertensive therapy on cognitive function in early executive cognitive impairment: A double-blind randomized clinical trial","volume":"172","author":"Hajjar","year":"2012","journal-title":"Archives of Internal Medicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109107_bb0345","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"Journal of Pathology"},{"issue":"9153","key":"10.1016\/j.pharmthera.2026.109107_bb0350","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0140-6736(98)05012-0","article-title":"Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The captopril prevention project (CAPPP) randomised trial","volume":"353","author":"Hansson","year":"1999","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109107_bb0355","doi-asserted-by":"crossref","DOI":"10.3390\/antiox10040552","article-title":"The interplay of RNA binding proteins, oxidative stress and mitochondrial dysfunction in ALS","volume":"10","author":"Harley","year":"2021","journal-title":"Antioxidants"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109107_bb0360","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s40262-013-0072-7","article-title":"Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects","volume":"52","author":"Haschke","year":"2013","journal-title":"Clinical Pharmacokinetics"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109107_bb0365","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1124\/jpet.118.254854","article-title":"A novel angiotensin-(1-7) glycosylated Mas receptor agonist for treating vascular cognitive impairment and inflammation-related memory dysfunction","volume":"369","author":"Hay","year":"2019","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109107_bb0370","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/pds.3449","article-title":"Time until incident dementia among Medicare beneficiaries using centrally acting or non-centrally acting ACE inhibitors","volume":"22","author":"Hebert","year":"2013","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109107_bb0375","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02638-2017","article-title":"A potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertension","volume":"51","author":"Hemnes","year":"2018","journal-title":"European Respiratory Journal"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113837","article-title":"ACE2 expression in rat brain: Implications for COVID-19 associated neurological manifestations","volume":"345","author":"Hern\u00e1ndez","year":"2021","journal-title":"Experimental Neurology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109107_bb0385","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1161\/HYPERTENSIONAHA.121.17049","article-title":"Blood-brain barrier crossing renin-angiotensin drugs and cognition in the elderly A meta-analysis","volume":"78","author":"Ho","year":"2021","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109107_bb0390","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"S1","key":"10.1016\/j.pharmthera.2026.109107_bb0395","doi-asserted-by":"crossref","DOI":"10.1152\/physiol.2023.38.S1.5735136","article-title":"A novel therapeutic Ang(1-7) analogue improves neurovascular function in mice with vascular contributions to cognitive impairment and dementia","volume":"38","author":"Hoyer-Kimura","year":"2023","journal-title":"Physiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109107_bb0400","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-021-02281-1","article-title":"Neurofilament light: A possible prognostic biomarker for treatment of vascular contributions to cognitive impairment and dementia","volume":"18","author":"Hoyer-Kimura","year":"2021","journal-title":"Journal of Neuroinflammation"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109107_bb0405","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1253\/circj.CJ-12-0658","article-title":"Angiotensin-receptor blockers and risk of Alzheimer\u2019s disease in hypertension population","volume":"77","author":"Hsu","year":"2013","journal-title":"Circulation Journal"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114314","article-title":"Claudin 5-binding small molecule transiently opens the blood-brain barrier and safely enhances brain drug delivery","volume":"388","author":"Inoue","year":"2025","journal-title":"Journal of Controlled Release"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109107_bb0415","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1111\/j.1476-5381.2012.02105.x","article-title":"Suppressing inflammation by inhibiting the NF-\u03baB pathway contributes to the neuroprotective effect of angiotensin-(1-7) in rats with permanent cerebral ischaemia","volume":"167","author":"Jiang","year":"2012","journal-title":"British Journal of Pharmacology"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109107_bb0420","doi-asserted-by":"crossref","first-page":"645","DOI":"10.18632\/aging.101419","article-title":"AVE0991, a nonpeptide analogue of Ang-(1-7), attenuates aging-related neuroinflammation","volume":"10","author":"Jiang","year":"2018","journal-title":"Aging"},{"issue":"18","key":"10.1016\/j.pharmthera.2026.109107_bb0425","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1111\/bph.12770","article-title":"Angiotensin-(1-7) induces cerebral ischaemic tolerance by promoting brain angiogenesis in a Mas\/eNOS-dependent pathway","volume":"171","author":"Jiang","year":"2014","journal-title":"British Journal of Pharmacology"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109107_bb0430","doi-asserted-by":"crossref","first-page":"8188","DOI":"10.1007\/s12035-018-0966-3","article-title":"Stimulation of ACE2\/ANG(1-7)\/Mas Axis by diminazene ameliorates Alzheimer\u2019s disease in the D-galactose-ovariectomized rat model: Role of PI3K\/Akt pathway","volume":"55","author":"Kamel","year":"2018","journal-title":"Molecular Neurobiology"},{"issue":"14","key":"10.1016\/j.pharmthera.2026.109107_bb0435","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23147686","article-title":"Renin-angiotensin system in Huntington\u2019s disease: Evidence from animal models and human patients","volume":"23","author":"Kangussu","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109107_bb0440","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1021\/cn500363g","article-title":"The implications of angiotensin-converting enzymes and their modulators in neurodegenerative disorders: Current and future perspectives","volume":"6","author":"Kaur","year":"2015","journal-title":"ACS Chemical Neuroscience"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109107_bb0445","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1177\/1352458508097923","article-title":"Angiotensin-converting enzyme (ACE) and ACE2 levels in the cerebrospinal fluid of patients with multiple sclerosis","volume":"15","author":"Kawajiri","year":"2009","journal-title":"Multiple Sclerosis Journal"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0450","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13195-016-0217-7","article-title":"Angiotensin-converting enzyme 2 is reduced in Alzheimer\u2019s disease in association with increasing amyloid-\u03b2 and tau pathology","volume":"8","author":"Kehoe","year":"2016","journal-title":"Alzheimer\u2019s Research & Therapy"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0455","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-017-1823-x","article-title":"A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome","volume":"21","author":"Khan","year":"2017","journal-title":"Critical Care"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109107_bb0460","doi-asserted-by":"crossref","first-page":"849","DOI":"10.4088\/JCP.11m07316","article-title":"The renin-angiotensin pathway in posttraumatic stress disorder: Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are associated with fewer traumatic stress symptoms","volume":"73","author":"Khoury","year":"2012","journal-title":"Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109107_bb0465","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-023-00622-7","article-title":"Neuropathology of incidental Lewy body & prodromal Parkinson\u2019s disease","volume":"18","author":"Koeglsperger","year":"2023","journal-title":"Molecular Neurodegeneration"},{"issue":"S1","key":"10.1016\/j.pharmthera.2026.109107_bb0470","first-page":"309","article-title":"Safety, tolerability and pharmacokinetic data of the novel orally active formulation of angiotensin-(1-7), Hydroxypropyl-\u03b2-cyclodextrin\/Ang-(1-7), in healthy volunteers-A randomized double-blinded controlled pilot study","volume":"68","author":"Koenen","year":"2016","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109107_bb0475","first-page":"5708","article-title":"Identifying genetic targets in clinical subtypes of Parkinson's disease for optimizing pharmacological treatment strategies","volume":"9","author":"Kong","year":"2024","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109107_bb0480","doi-asserted-by":"crossref","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: The roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Translational Neurodegeneration"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109813","article-title":"Mas-related G protein-coupled receptor D participates in inflammatory pain by promoting NF-\u03baB activation through interaction with TAK1 and IKK complex","volume":"76","author":"Lan","year":"2020","journal-title":"Cellular Signalling"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109107_bb0490","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/CIRCRESAHA.113.301077","article-title":"Discovery and characterization of alamandine a novel component of the renin-angiotensin system","volume":"112","author":"Lautner","year":"2013","journal-title":"Circulation Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109107_bb0495","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.nlm.2011.10.003","article-title":"Angiotensin-(1-7)\/Mas axis integrity is required for the expression of object recognition memory","volume":"97","author":"Lazaroni","year":"2012","journal-title":"Neurobiology of Learning and Memory"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109107_bb0500","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.taap.2008.01.039","article-title":"Involvement of cyclin D1\/CDK4 and pRb mediated by PI3K\/AKT pathway activation in Pb2+\u2212induced neuronal death in cultured hippocampal neurons","volume":"229","author":"Li","year":"2008","journal-title":"Toxicology and Applied Pharmacology"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109107_bb0505","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1179\/1973947813Y.0000000094","article-title":"CJY, an isoflavone, interacts with ATPase of P-glycoprotein in the rat brain microvessel endothelial cells (RBMECs)","volume":"25","author":"Li","year":"2013","journal-title":"Journal of Chemotherapy"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0510","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b5465","article-title":"Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: Prospective cohort analysis","volume":"340","author":"Li","year":"2010","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"S1","key":"10.1016\/j.pharmthera.2026.109107_bb0520","article-title":"Recombinant probiotics expressing angiotensin-(1-7) improves glucose metabolism and diabetes-induced renal and retinal injury","volume":"67","author":"Li","year":"2018","journal-title":"Diabetes"},{"issue":"5\u20136","key":"10.1016\/j.pharmthera.2026.109107_bb0525","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1089\/neu.2021.0382","article-title":"Restoration of brain angiotensin-converting enzyme 2 alleviates neurological deficits after severe traumatic brain injury via mitigation of pyroptosis and apoptosis","volume":"39","author":"Li","year":"2022","journal-title":"Journal of Neurotrauma"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109107_bb0530","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s12253-018-0471-z","article-title":"Suppression of angiotensin-(1-7) on the disruption of blood-brain barrier in rat of brain glioma","volume":"25","author":"Li","year":"2019","journal-title":"Pathology & Oncology Research"},{"issue":"16","key":"10.1016\/j.pharmthera.2026.109107_bb0540","doi-asserted-by":"crossref","first-page":"8779","DOI":"10.1039\/C7RA09136B","article-title":"Angiotensin-(1-7) attenuates hypertension and cardiac hypertrophy via modulation of nitric oxide and neurotransmitter levels in the paraventricular nucleus in salt-sensitive hypertensive rats","volume":"8","author":"Liang","year":"2018","journal-title":"RSC Advances"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109107_bb0545","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.amjmed.2022.04.029","article-title":"Association of Angiotensin Receptor Blockers with incident Parkinson disease in patients with hypertension: A retrospective cohort study","volume":"135","author":"Lin","year":"2022","journal-title":"American Journal of Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109107_bb0550","article-title":"Advances in brain-targeted delivery strategies and natural product-mediated enhancement of blood-brain barrier permeability","volume":"23","author":"Liu","year":"2025","journal-title":"Journal of Nanobiotechnology"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109107_bb0555","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/jnr.23404","article-title":"Conversion of A\u03b243 to A\u03b240 by the successive action of angiotensin-converting enzyme 2 and angiotensin-converting enzyme","volume":"92","author":"Liu","year":"2014","journal-title":"Journal of Neuroscience Research"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102804","article-title":"Synergistic pathways in Parkinson's disease: The promise of FGF21 and ACE2","volume":"110","author":"Liu","year":"2025","journal-title":"Ageing Research Reviews"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0565","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.neuroscience.2024.06.024","article-title":"The role of ACE2 in RAS axis on microglia activation in Parkinson\u2019s disease","volume":"553","author":"Liu","year":"2024","journal-title":"Neuroscience"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109107_bb0570","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/s41582-025-01154-y","article-title":"Towards pharmacological prevention of Alzheimer disease","volume":"21","author":"Llibre-Guerra","year":"2025","journal-title":"Nature Reviews Neurology"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109107_bb0575","first-page":"673","article-title":"CNP\/cGMP signaling regulates axon branching and growth by modulating microtubule polymerization","volume":"73","author":"Ma","year":"2013","journal-title":"Society for Neuroscience Abstract Viewer and Itinerary Planner"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109107_bb0580","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1159\/000526982","article-title":"Cardiovascular diseases, medications, and ALS: A population-based case-control study","volume":"56","author":"Magid","year":"2023","journal-title":"Neuroepidemiology"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109107_bb0585","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/HJH.0b013e3283603f53","article-title":"Antihypertensive classes, cognitive decline and incidence of dementia: A network meta-analysis","volume":"31","author":"Marpillat","year":"2013","journal-title":"Journal of Hypertension"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109107_bb0595","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13513","article-title":"An update on ACE2 amplification and its therapeutic potential","volume":"231","author":"Marquez","year":"2021","journal-title":"Acta Physiologica"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109107_bb0600","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1113\/expphysiol.2011.058578","article-title":"Cerebroprotection by angiotensin-(1-7) in endothelin-1-induced ischaemic stroke","volume":"96","author":"Mecca","year":"2011","journal-title":"Experimental Physiology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109107_bb0605","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41590-021-01104-y","article-title":"Pathological sequelae of long-haul COVID","volume":"23","author":"Mehandru","year":"2022","journal-title":"Nature Immunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109107_bb0610","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/1470320309347789","article-title":"The role of the central renin-angiotensin system in Parkinson's disease","volume":"11","author":"Mertens","year":"2010","journal-title":"Journal of the Renin-Angiotensin-Aldosterone System"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.cophys.2025.100891","article-title":"Chronic vs acute effects of central angiotensin (1-7) on blood pressure: A region-specific perspective","volume":"47","author":"Minczuk","year":"2026","journal-title":"Current Opinion in Physiology"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0620","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.110279","article-title":"Angiotensin 1-7 injected into the rat paraventricular nucleus of hypothalamus increases blood pressure and heart rate via various receptors","volume":"266","author":"Minczuk","year":"2025","journal-title":"Neuropharmacology"},{"issue":"S1","key":"10.1016\/j.pharmthera.2026.109107_bb0625","doi-asserted-by":"crossref","DOI":"10.1096\/fasebj.2022.36.S1.R4386","article-title":"ACE2 ubiquitination in the paraventricular nucleus of the hypothalamus contributes to angiotensin-II-induced hypertension in mice","volume":"36","author":"Mohammed","year":"2022","journal-title":"FASEB Journal"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109107_bb0630","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1093\/cvr\/cvad070","article-title":"Nedd4-2 up-regulation is associated with ACE2 ubiquitination in hypertension","volume":"119","author":"Mohammed","year":"2023","journal-title":"Cardiovascular Research"},{"issue":"13","key":"10.1016\/j.pharmthera.2026.109107_bb0635","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1080\/15384101.2023.2228089","article-title":"Mas receptor: A potential strategy in the management of ischemic cardiovascular diseases","volume":"22","author":"Molaei","year":"2023","journal-title":"Cell Cycle"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109107_bb0640","doi-asserted-by":"crossref","DOI":"10.1186\/s13041-023-01040-y","article-title":"Activation of angiotensin-converting enzyme 2 produces an antidepressant-like effect via MAS receptors in mice","volume":"16","author":"Nakagawasai","year":"2023","journal-title":"Molecular Brain"},{"issue":"S4","key":"10.1016\/j.pharmthera.2026.109107_bb0645","doi-asserted-by":"crossref","DOI":"10.1002\/alz.069349","article-title":"Genetically proxied angiotensin-converting-enzyme inhibition is potentially causal for Alzheimer disease: A Mendelian randomization study","volume":"18","author":"Nassan","year":"2022","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"5117","key":"10.1016\/j.pharmthera.2026.109107_bb0650","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/216762a0","article-title":"Conversion of angiotensin I to angiotensin II","volume":"216","author":"Ng","year":"1967","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0655","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2024.111198","article-title":"Captopril prevents depressive-like behavior in an animal model of depression by enhancing hippocampal neurogenesis via activation of the ACE2\/Ang (1-7)\/Mas receptor\/AMPK\/BDNF pathway","volume":"136","author":"Odaira-Satoh","year":"2025","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0660","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1223733","article-title":"ACE2 overexpression in corticotropin-releasing-hormone cells offers protection against pulmonary hypertension","volume":"17","author":"Oliveira","year":"2023","journal-title":"Frontiers in Neuroscience"},{"issue":"S15","key":"10.1016\/j.pharmthera.2026.109107_bb0665","doi-asserted-by":"crossref","DOI":"10.1002\/alz.072576","article-title":"Biofluid activity and levels of the angiotensin-converting enzyme may translate into distinct neuropsychiatric symptoms associated with cerebrospinal fluid amyloid-beta effects and tauopathy in dementia with Lewy bodies and Alzheimer\u2019s dementia","volume":"19","author":"de Oliveira","year":"2023","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0670","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.2147\/JIR.S307801","article-title":"The ACE2-Ang-(1-7)-Mas axis modulates M1\/M2 macrophage polarization to relieve CLP-induced inflammation via TLR4-mediated NF-\u03bab and MAPK pathways","volume":"14","author":"Pan","year":"2021","journal-title":"Journal of Inflammation Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109107_bb0675","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1007\/s12035-023-03280-4","article-title":"MiR-17-5p mediates the effects of ACE2-enriched endothelial progenitor cell-derived exosomes on ameliorating cerebral ischemic injury in aged mice","volume":"60","author":"Pan","year":"2023","journal-title":"Molecular Neurobiology"},{"issue":"7\u20138","key":"10.1016\/j.pharmthera.2026.109107_bb0680","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1042\/CS20120461","article-title":"Angiotensin-(1-7): Beyond the cardio-renal actions","volume":"124","author":"Passos-Silva","year":"2013","journal-title":"Clinical Science"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109107_bb0685","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21051769","article-title":"EPA is more effective than DHA to improve depression-like behavior, glia cell dysfunction and hippcampal apoptosis signaling in a chronic stress-induced rat model of depression","volume":"21","author":"Peng","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109107_bb0690","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1080\/13543784.2017.1371133","article-title":"Renin-angiotensin system as a potential target for new therapeutic approaches in Parkinson\u2019s disease","volume":"26","author":"Perez-Lloret","year":"2017","journal-title":"Expert Opinion on Investigational Drugs"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0695","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102854","article-title":"Is the renin-angiotensin system a friend or foe in neurological diseases? Unveiling its role and therapeutic potential","volume":"112","author":"Porel","year":"2025","journal-title":"Ageing Research Reviews"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109107_bb0700","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: Progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nature Reviews Drug Discovery"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0705","doi-asserted-by":"crossref","DOI":"10.1186\/s13041-017-0340-9","article-title":"Oxidative stress and cellular pathologies in Parkinson\u2019s disease","volume":"10","author":"Puspita","year":"2017","journal-title":"Molecular Brain"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109107_bb0710","article-title":"Signaling pathways involved in ischemic stroke: Molecular mechanisms and therapeutic interventions","volume":"7","author":"Qin","year":"2022","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109107_bb0715","first-page":"3180","article-title":"Modulation of mitochondrial dynamics by the angiotensin system in dopaminergic neurons and microglia","volume":"16","author":"Quijano","year":"2025","journal-title":"Aging and Disease"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0720","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.04.014","article-title":"Improvements of symptoms of Alzheimer's disease by inhibition of the angiotensin system","volume":"154","author":"Quitterer","year":"2020","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0725","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.bcp.2018.01.047","article-title":"Angiotensin 1-7 ameliorates 6-hydroxydopamine lesions in hemiparkinsonian rats through activation of MAS receptor\/PI3K\/Akt\/BDNF pathway and inhibition of angiotensin II type-1 receptor\/NF-\u03baB axis","volume":"151","author":"Rabie","year":"2018","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0730","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.brainres.2018.10.006","article-title":"Plasma levels of brain-derived neurotrophic factor in patients with Parkinson disease: A systematic review and meta-analysis","volume":"1704","author":"Rahmani","year":"2019","journal-title":"Brain Research"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109107_bb0735","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000210063","article-title":"Endothelial cell senescence effect on the blood-brain barrier in stroke and cognitive impairment","volume":"103","author":"Real","year":"2024","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109107_bb0740","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1445-5994.2000.tb01054.x","article-title":"The angiotensin converting enzyme (ACE) inhibitor, perindopril, modifies the clinical features of Parkinson\u2019s disease","volume":"30","author":"Reardon","year":"2000","journal-title":"Australian and New Zealand Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0745","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.neuropharm.2013.03.025","article-title":"Anti-inflammatory effects of angiotensin-(1-7) in ischemic stroke","volume":"71","author":"Regenhardt","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0750","first-page":"1625","article-title":"Blood pressure and secondary prevention of strokes - how low should we go?","volume":"48","author":"Rezaiefar","year":"2002","journal-title":"Canadian Family Physician"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0755","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.636754","article-title":"Circulating angiotensin-(1-7) is reduced in Alzheimer\u2019s disease patients and correlates with white matter abnormalities: Results from a pilot study","volume":"15","author":"Ribeiro","year":"2021","journal-title":"Frontiers in Neuroscience"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109107_bb0760","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2003-4-8-225","article-title":"Angiotensin-I-converting enzyme and its relatives","volume":"4","author":"Riordan","year":"2003","journal-title":"Genome Biology"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0765","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.594945","article-title":"Peripheral levels of renin-angiotensin system components are associated with cognitive performance in Huntington\u2019s disease","volume":"14","author":"Rocha","year":"2020","journal-title":"Frontiers in Neuroscience"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109107_bb0770","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/ALN.0000000000001404","article-title":"Withholding versus continuing angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers before noncardiac surgery An analysis of the vascular events in noncardiac surgery patlents cohort evaluatioN prospective cohort","volume":"126","author":"Roshanov","year":"2017","journal-title":"Anesthesiology"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109107_bb0775","doi-asserted-by":"crossref","first-page":"242","DOI":"10.4103\/0022-3859.188553","article-title":"Can angiotensin-converting enzyme inhibitors impact cognitive decline in early stages of Alzheimer's disease? An overview of research evidence in the elderly patient population","volume":"62","author":"Rygiel","year":"2016","journal-title":"Journal of Postgraduate Medicine"},{"issue":"3\u20134","key":"10.1016\/j.pharmthera.2026.109107_bb0780","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1527-3466.2006.00239.x","article-title":"Pharmacological effects of AVE 0991, a nonpeptide angiotensin-(1-7) receptor agonist","volume":"24","author":"Santos","year":"2006","journal-title":"Cardiovascular Drug Reviews"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109107_bb0785","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JOE-12-0341","article-title":"Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: New players of the renin-angiotensin system","volume":"216","author":"Santos","year":"2013","journal-title":"Journal of Endocrinology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109107_bb0790","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1161\/01.HYP.0000052947.60363.24","article-title":"Characterization of a new selective antagonist for angiotensin-(1-7), D-Pro7-angiotensin-(1-7)","volume":"41","author":"Santos","year":"2003","journal-title":"Hypertension"},{"issue":"14","key":"10.1016\/j.pharmthera.2026.109107_bb0795","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1073\/pnas.1432869100","article-title":"Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas","volume":"100","author":"Santos","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109107_bb0800","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0197-4580(00)00259-1","article-title":"Cortical alterations of angiotensin converting enzyme, angiotensin II and AT1 receptor in Alzheimer's dementia","volume":"22","author":"Savaskan","year":"2001","journal-title":"Neurobiology of Aging"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109107_bb0805","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1161\/HYPERTENSIONAHA.110.152942","article-title":"Vascular relaxation, antihypertensive effect, and cardioprotection of a novel peptide agonist of the Mas receptor","volume":"56","author":"Savergnini","year":"2010","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109107_bb0810","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/j.neuron.2022.02.020","article-title":"Mechanisms of memory under stress","volume":"110","author":"Schwabe","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0815","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jad.2019.10.004","article-title":"Is there an association between anxiety symptoms and valsartan treatment?","volume":"261","author":"Shad","year":"2020","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0590","doi-asserted-by":"crossref","first-page":"795452","DOI":"10.1155\/2012\/795452","article-title":"Beneficial effects of long-term administration of an oral formulation of angiotensin-(1-7) in infarcted rats","volume":"2012","author":"Marques","year":"2012","journal-title":"International Journal of Hypertension"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0820","doi-asserted-by":"crossref","unstructured":"Shen, Y., Lamptey, R. N. L., Mareddy, G. R., Chaulagain, B., Singh, J., & Sun, C. W. (2025). Engineered liposomal delivery of human ACE2 across the blood-brain barrier attenuated neurogenic hypertension. Pharmaceutics, 17(10), article 1329. https:\/\/doi.org\/10.3390\/pharmaceutics17101329.","DOI":"10.3390\/pharmaceutics17101329"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109107_bb0825","doi-asserted-by":"crossref","first-page":"16291","DOI":"10.1096\/fj.202001639R","article-title":"Angiotensin-(1-7), the product of ACE2 ameliorates NAFLD by acting through its receptor Mas to regulate hepatic mitochondrial function and glycolipid metabolism","volume":"34","author":"Song","year":"2020","journal-title":"FASEB Journal"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109107_bb0830","doi-asserted-by":"crossref","DOI":"10.1007\/s11906-018-0798-6","article-title":"Angiotensin-(1-7) and alamandine on experimental models of hypertension and atherosclerosis","volume":"20","author":"de Souza-Neto","year":"2018","journal-title":"Current Hypertension Reports"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109107_bb0835","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nn1676","article-title":"Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia","volume":"9","author":"Spudich","year":"2006","journal-title":"Nature Neuroscience"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109107_bb0840","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052557","article-title":"Angiotensin II and angiotensin-(1-7) in paraventricular nucleus modulate cardiac sympathetic afferent reflex in renovascular hypertensive rats","volume":"7","author":"Sun","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109107_bb0845","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/jnnp-2014-308948","article-title":"Preadmission use of ACE inhibitors or angiotensin receptor blockers and short-term mortality after stroke","volume":"86","author":"Sundboll","year":"2015","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109107_bb0850","doi-asserted-by":"crossref","DOI":"10.1172\/JCI164199","article-title":"TIMP2 ameliorates blood-brain barrier disruption in traumatic brain injury by inhibiting Src-dependent VE-cadherin internalization","volume":"134","author":"Tang","year":"2024","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0855","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.exger.2016.11.004","article-title":"Impaired neurovascular coupling in aging and Alzheimer\u2019s disease: Contribution of astrocyte dysfunction and endothelial impairment to cognitive decline","volume":"94","author":"Tarantini","year":"2017","journal-title":"Experimental Gerontology"},{"issue":"43","key":"10.1016\/j.pharmthera.2026.109107_bb0860","doi-asserted-by":"crossref","first-page":"33238","DOI":"10.1074\/jbc.M002615200","article-title":"A human homolog of angiotensin-converting enzyme - cloning and functional expression as a captopril-insensitive carboxypeptidase","volume":"275","author":"Tipnis","year":"2000","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0865","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112654","article-title":"Effect of diminazene aceturate, an ACE2 activator, on platelet CD40L signaling induced glial activation in rat model of hypertension","volume":"139","author":"Tiwari","year":"2024","journal-title":"International Immunopharmacology"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109107_bb0870","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S1357-2725(02)00273-X","article-title":"Bradykinin, angiotensin-(1-7), and ACE inhibitors: How do they interact?","volume":"35","author":"Tom","year":"2003","journal-title":"International Journal of Biochemistry & Cell Biology"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0875","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9293553","article-title":"Recent advances in the endogenous brain renin-angiotensin system and drugs acting on it","volume":"2021","author":"Urmila","year":"2021","journal-title":"Journal of the Renin-Angiotensin-Aldosterone System"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0880","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104778","article-title":"Dysregulated anti-oxidant signalling and compromised mitochondrial integrity negatively influence regulatory T cell function and viability in liver disease","volume":"95","author":"Vaikunthanathan","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0885","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102078","article-title":"An ACE2\/Mas-related receptor MrgE axis in dopaminergic neuron mitochondria","volume":"46","author":"Valenzuela","year":"2021","journal-title":"Redox Biology"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109107_bb0890","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1007\/s11064-023-03904-0","article-title":"Mitochondrial dysfunction and Parkinson\u2019s disease: Pathogenesis and therapeutic strategies","volume":"48","author":"Vastegani","year":"2023","journal-title":"Neurochemical Research"},{"issue":"17","key":"10.1016\/j.pharmthera.2026.109107_bb0895","doi-asserted-by":"crossref","first-page":"14838","DOI":"10.1074\/jbc.M200581200","article-title":"Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase","volume":"277","author":"Vickers","year":"2002","journal-title":"Journal of Biological Chemistry"},{"issue":"14","key":"10.1016\/j.pharmthera.2026.109107_bb0900","doi-asserted-by":"crossref","first-page":"R713","DOI":"10.1016\/j.cub.2017.05.064","article-title":"Animal communication: When I\u2019m calling you, will you answer too?","volume":"27","author":"Vickers","year":"2017","journal-title":"Current Biology"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109107_bb0905","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1042\/CS20130515","article-title":"Angiotensin type 2 receptor (AT2R) and receptor mas: A complex liaison","volume":"128","author":"Villela","year":"2015","journal-title":"Clinical Science"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109107_bb0910","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-021-00818-7","article-title":"Neurological complications and infection mechanism of SARS-COV-2","volume":"6","author":"Wan","year":"2021","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109107_bb0915","doi-asserted-by":"crossref","DOI":"10.1186\/s43094-024-00724-z","article-title":"The potential therapeutic role of Lisinopril in augmenting the striatal neuroplasticity via the striatal ACE2\/Ang1-7\/MAS receptor axis in 3-nitropropionic acid-induced Huntington\u2019s disease in rats: Shifting paradigms in Huntington\u2019s disease treatment","volume":"10","author":"Wanas","year":"2024","journal-title":"Future Journal of Pharmaceutical Sciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109107_bb0920","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cell.2021.12.003","article-title":"BDNF signaling in context: From synaptic regulation to psychiatric disorders","volume":"185","author":"Wang","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0925","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2018.00376","article-title":"Dysfunction of cerebrovascular endothelial cells: Prelude to vascular dementia","volume":"10","author":"Wang","year":"2018","journal-title":"Frontiers in Aging Neuroscience"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0935","article-title":"Exosome-mediated transfer of ACE2 (angiotensin-converting enzyme 2) from endothelial progenitor cells promotes survival and function of endothelial cell","volume":"2020","author":"Wang","year":"2020","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0940","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neuropharm.2015.12.026","article-title":"Increasing brain angiotensin converting enzyme 2 activity decreases anxiety-like behavior in male mice by activating central Mas receptors","volume":"105","author":"Wang","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0955","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3389\/fendo.2013.00158","article-title":"A role for the brain RAS in Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"4","author":"Wright","year":"2013","journal-title":"Frontiers in Endocrinology"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0960","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejphar.2014.12.007","article-title":"Ang-(1-7) exerts protective role in blood-brain barrier damage by the balance of TIMP-1\/MMP-9","volume":"748","author":"Wu","year":"2015","journal-title":"European Journal of Pharmacology"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109107_bb0965","doi-asserted-by":"crossref","first-page":"R370","DOI":"10.1152\/ajpregu.00366.2014","article-title":"Brain ACE2 overexpression reduces DOCA-salt hypertension independently of endoplasmic reticulum stress","volume":"308","author":"Xia","year":"2015","journal-title":"American Journal of Physiology. Regulatory, Integrative and Comparative Physiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109107_bb0970","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.yexcr.2015.06.010","article-title":"Angiotensin-(1-7) counteracts angiotensin II-induced dysfunction in cerebral endothelial cells via modulating Nox2\/ROS and PI3K\/NO pathways","volume":"336","author":"Xiao","year":"2015","journal-title":"Experimental Cell Research"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0975","doi-asserted-by":"crossref","first-page":"4364","DOI":"10.1007\/s10753-025-02331-3","article-title":"ACE2 alleviates microglia neuroinflammation by RANK-RANKL-OPG axis in Parkinson\u2019s disease","volume":"48","author":"Xu","year":"2025","journal-title":"Inflammation"},{"issue":"6485","key":"10.1016\/j.pharmthera.2026.109107_bb0980","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109107_bb0985","doi-asserted-by":"crossref","DOI":"10.1186\/s40779-025-00591-6","article-title":"Build the virtual cell with artificial intelligence: A perspective for cancer research","volume":"12","author":"Yang","year":"2025","journal-title":"Military Medical Research"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109107_bb0990","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1212\/WNL.0b013e3182a35228","article-title":"Antihypertensive drugs decrease risk of Alzheimer disease ginkgo evaluation of memory study","volume":"81","author":"Yasar","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2026.109107_bb0995","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117628","article-title":"Piperine promotes PI3K\/AKT\/mTOR-mediated gut-brain autophagy to degrade \u03b1-synuclein in Parkinson\u2019s disease rats","volume":"322","author":"Yu","year":"2024","journal-title":"Journal of Ethnopharmacology"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109107_bb1000","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1056\/NEJMoa0804593","article-title":"Telmisartan to prevent recurrent stroke and cardiovascular events","volume":"359","author":"Yusuf","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"15","key":"10.1016\/j.pharmthera.2026.109107_bb1005","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"358","author":"Yusuf","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"22","key":"10.1016\/j.pharmthera.2026.109107_bb1010","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1038\/emboj.2013.207","article-title":"Amyloid-\u03b2 oligomers induce synaptic damage via tau-dependent microtubule severing by TTLL6 and spastin","volume":"32","author":"Zempel","year":"2013","journal-title":"EMBO Journal"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109107_bb1015","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/ame2.12324","article-title":"Overexpression of ACE2 ameliorates a\u03b2-induced blood-brain barrier damage and angiogenesis by inhibiting NF-\u03baB\/VEGF\/VEGFR2 pathway","volume":"6","author":"Zhang","year":"2023","journal-title":"Animal Models and Experimental Medicine"},{"issue":"5\u20136","key":"10.1016\/j.pharmthera.2026.109107_bb1020","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.npep.2008.09.005","article-title":"Central administration of angiotensin-(1-7) stimulates nitric oxide release and upregulates the endothelial nitric oxide synthase expression following focal cerebral ischemia\/reperfusion in rats","volume":"42","author":"Zhang","year":"2008","journal-title":"Neuropeptides"},{"key":"10.1016\/j.pharmthera.2026.109107_bb1025","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107717","article-title":"Multidimensional mechanisms of anxiety and depression in Parkinson\u2019s disease: Integrating neuroimaging, neurocircuits, and molecular pathways","volume":"215","author":"Zhao","year":"2025","journal-title":"Pharmacological Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109107_bb1030","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1021\/acscentsci.3c00377","article-title":"A triple-targeted Rutin-based self-assembled delivery vector for treating ischemic stroke by vascular normalization and anti-inflammation via ACE2\/Ang1-7 signaling","volume":"9","author":"Zhao","year":"2023","journal-title":"ACS Central Science"},{"key":"10.1016\/j.pharmthera.2026.109107_bb1035","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neuroscience.2014.04.060","article-title":"Activation of the ACE2\/Ang-(1-7)\/Mas pathway reduces oxygen-glucose deprivation-induced tissue swelling, ROS production, and cell death in mouse brain with angiotensin II overproduction","volume":"273","author":"Zheng","year":"2014","journal-title":"Neuroscience"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725826001348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725826001348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T20:24:00Z","timestamp":1788726240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725826001348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":202,"alternative-id":["S0163725826001348"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2026.109107","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The brain angiotensin converting enzyme 2 and angiotensin-(1\u20137) as potential therapeutic targets for the central nervous system diseases","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2026.109107","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109107"}}